40K PEGylated recombinant factor IX

40K PEGylated recombinant factor IX
Trade Name
Orphan Indication Hemophilia B
USA Market Approval USA
USA Designation Date 2013-03-18 00:00:00
Sponsor Novo Nordisk, Inc.;100 College Road West;Princeton, 08540